Icosapent ethyl reduces atherogenic markers in high-risk statin-treated patients with stage 3 chronic kidney disease and high triglycerides-Reference-Cited by-同舟云学术

Icosapent ethyl reduces atherogenic markers in high-risk statin-treated patients with stage 3 chronic kidney disease and high triglycerides

Published:2019-07-25 Issue:6 Volume:131 Page:390-396
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Vijayaraghavan Krishnaswami¹,Szerlip Harold M.²,Ballantyne Christie M.³,Bays Harold E.⁴,Philip Sephy⁵,Doyle Ralph T.⁶,Juliano Rebecca A.⁶,Granowitz Craig⁵

Affiliation:

1. Institute of Congestive Heart Failure, Abrazo Arizona Heart Hospital, Phoenix, AZ, USA

2. Nephrology Division and Nephrology Fellowship Program, Baylor University Medical Center, Dallas, TX, USA

3. Department of Medicine, Baylor College of Medicine and the Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA

4. Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY, USA

5. Medical Affairs, Amarin Pharma Inc., Bedminster, NJ, USA

6. Clinical Development, Amarin Pharma Inc., Bedminster, NJ, USA

Funder

Amarin Pharma Inc

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00325481.2019.1643633

Reference42 articles.

1. Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization

2. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention

3. Prognostic Value of Chronic Kidney Disease Measures in Patients With Cardiac Disease

4. Longitudinal Follow-up and Outcomes Among a Population With Chronic Kidney Disease in a Large Managed Care Organization

5. KDOQI US Commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Dietary Interventions on Hypertriglyceridemia: From Public Health to Molecular Nutrition Evidence;Nutrients;2022-03-05

2. Early Investigational and Experimental Therapeutics for the Treatment of Hypertriglyceridemia;Journal of Cardiovascular Development and Disease;2022-01-25

3. Egyptian practical guidance in hypertriglyceridemia management 2021;The Egyptian Heart Journal;2021-12

4. Micronutrients, Phytochemicals and Mediterranean Diet: A Potential Protective Role against COVID-19 through Modulation of PAF Actions and Metabolism;Nutrients;2021-01-30

5. Three Cases of COVID-19 Pneumonia That Responded to Icosapent Ethyl Supportive Treatment;American Journal of Case Reports;2020-12-14